Center-Authored Papers

Filters: Author is Chauncey, Thomas  [Clear All Filters]
2002
Maciej Zaucha J, Mielcarek M, Takatu A, Little M-T, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T et al..  2002.  Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.. British journal of haematology. 119(3):740-50. Abstract
Mielcarek M, Sandmaier BM, Maloney DG, Maris M, McSweeney PA, Woolfrey A, Chauncey T, Feinstein L, Niederwieser D, Blume KG et al..  2002.  Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.. Journal of clinical immunology. 22(2):70-4. Abstract
2012
Bensinger WI, Rotta M, Storer B, Chauncey T, Holmberg L, Becker P, Sandmaier BM, Storb R, Maloney D.  2012.  Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center.. Bone marrow transplantation. 47(10):1312-7. Abstract
2013
Bar M, Sandmaier BM, Inamoto Y, Bruno B, Hari P, Chauncey T, Martin P, Storb R, Maloney DG, Storer B et al..  2013.  Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3(+) T Cell Dose.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(6):949-957. Abstract
2015
Phipps C, Gopal AK, Storer BE, Cassaday RD, Press OW, Till BG, Pagel JM, Palanca-Wessels MC, Philip M, Bensinger WI et al..  2015.  Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity.. Leukemia & lymphoma. 56(1):92-6. Abstract